Richa S. Email & Phone Number

Minnesota, United States

Mn/Nd

Mn/Nd

**Akcea was acquired by Ionis Pharmaceuticals**Responsible for company's first launch of TEGSEDI to healthcare practitioners and Institutions by educating HCPs on the disease state, its signs/symptoms, and logistics behind genetic testing to identify appropriate patients. In addition, I play a critical role in working with and developing key academic medical centers, Amyloidosis Centers of Excellence, Key Thought leaders and community-based practitioners focusing on the testing, management and/or treatment of patients with hATTR amyloidosis. Furthermore, as a Field Marketing Liaison, I collaborate with Marketing, KOLs and internal stakeholders to help facilitate and develop field resources to be utilized by the sales team for effective messaging.

Mn, Ia, Sd, Nd

**Formerly Baxalta, Baxter Bioscience**Responsible for selling rare-disease biologic infusion therapies along with associated devices for Hemophilia and Von Willebrand disease to Hemophilia Treatment Centers, Hematologist/Oncologists, 340b hospital pharmacies, Biological Distributors, Specialty Pharmacies, local Hemophilia chapters and Patients/caregivers. Responsible in hospitals and outpatient settings for Hematology products: Hemophilia A (Adynovate, Advate), Hemophilia B (Rixubis), Von Willebrand Disease (Vonvendi), Hemophilia with inhibitors (Feiba), and Acquired Hemophilia (Obizur). Demonstrated medical device used for infusion therapy to nurses, pharmacists, and patients/caregivers.

Greater Minneapolis-St. Paul Area

**Formerly Forest Labs and Actavis**

Greater Minneapolis-St. Paul Area

St. Louis, Mo

Overland Park, Ks